#ASCO24 is underway and we're excited to connect with the oncology community! Stop by booth #28115 to learn more about our end-to-end precision oncology solutions and our work to disrupt the paradigm of cancer monitoring.
Guardant Health’s Post
More Relevant Posts
-
The speed of innovation and steepness of cost trend in the oncology drug space is at an all-time high. Using a collaborative model like ours to increase the use of higher-value (which, by the way, does not always mean lowest cost) treatment regimens is one of many important tools we can deploy to address this need.
With the prevalence of cancer and the rapid increase in cancer treatment costs, a value-based approach is critical to ensure the best possible cancer care without unnecessary spending. Learn how eviCore’s Oncology Value-based Pathways program is helping: https://bit.ly/4aHbOj5
To view or add a comment, sign in
-
With the prevalence of cancer and the rapid increase in cancer treatment costs, a value-based approach is critical to ensure the best possible cancer care without unnecessary spending. Learn how eviCore’s Oncology Value-based Pathways program is helping: https://bit.ly/4aHbOj5
To view or add a comment, sign in
-
It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://lnkd.in/gRc_wcPh Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment
To view or add a comment, sign in
-
Vice President, Head of Global Medical Affairs (Solid Tumors) @ Stemline Therapeutics, a Menarini Group Company
#ESMO2024 is about to start! Once more, another chance to discuss about #research and groundbreaking #treatments, generate insights, and reassure our #commitment to bring #innovation to #patients Let’s connect, learn, discuss, and continue working tirelessly to bend survival curves. Ping me if you are around and interested on learning about us!
Our team is heading to Barcelona this week to connect with the global oncology community at #ESMO24! Be sure to visit our booth to learn more about Menarini Stemline’s focus on bringing transformational oncology treatments to people living with cancer.
To view or add a comment, sign in
-
In light of significant strides in cancer treatment and prevention, a diagnosis no longer carries the grim prognosis it once did. Join us at #SXSW2024 for our “Rebranding Cancer” panel where experts will delve into reshaping the perception of cancer from one of fear to a more accurate portrayal of the advancements in oncology. Learn more about our panel and download the Oncology Inflection here: https://bit.ly/3SPZBkd
To view or add a comment, sign in
-
Although, certain habits may increase your chances of acquiring cancer, abstaining from them doesn’t eliminate your risks. Discover the truth about cancer with our expert, Dr. Surender Kumar Dabas, Vice Chairman, Oncology. Learn why regular check-ups are your best defense against cancer. #CancerAwareness #Prevention #Oncology #BLKMaxSuperSpecialityHospital
To view or add a comment, sign in
-
It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/4ewD8CF Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment
To view or add a comment, sign in
-
It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/3KWYk7p Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment
To view or add a comment, sign in
-
The course covers a wide range of topics, including the foundations of cancer, the current global state of cancer and the types of cancer treatments available today. It highlights the challenges in oncology clinical trials, such as patient recruitment, participant risks of serious adverse events, resource limitations, funding disparities, endpoint selection, complex protocols, and diversity concerns. #TransformingOncology #ClinicalResearch #OncologyTrials #LifelongLearning
To view or add a comment, sign in
-
With more than 22,000 registrants and more than 240 clinical trials presented, the annual American Association for Cancer Research (AACR) conference had a lot happening! Read some of the highlights and key takeaways from Meredith Manuel, Executive Director, Catalyst Oncology Consulting. She provides her take on sessions about accelerated approvals, cancer vaccines, and big data and AI in oncology studies. You don't want to miss it! https://lnkd.in/eZvS2PpA #AACR24 #BigData #PrecisionMedicine #OncologyConsulting
To view or add a comment, sign in
182,570 followers